Orthofix Medical Inc. (OFIX), Tuesday announced first-quarter financial results, reporting a net loss of $53.1 million, or $1.35 a share, compared to a net loss of $36.02 million, or $0.95 a share, last year.
On adjusted basis, loss totaled $3.2 million versus a loss of $4.7 million in the prior year.
Net sales for the quarter were $193.6 million compared to $188.6 million in the previous year.
Looking forward, the company anticipates net sales to range between $808 million to $816 million for the full year 2025.
In the pre-market hours, Orthofix's stock is moving down 23.86 percent, to $10.31 on the Nasdaq.
For comments and feedback: editorial@rttnews.com